HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a biotechnology company developing regenerative medicine therapies, initially for trachea cancer, was featured November 27 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Help employers find you! Check out all the jobs and post your resume.
